UBS AM
EXAS

UBS AM’s Exact Sciences EXAS Stock Holding History

UBS AM’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-615,940
Closed -$62.6M – 3829
2025
Q4 		$62.6M Sell
615,940
-974,187
-61% -$78.2M 0.01% 571
2025
Q3 		$87M Sell
1,590,127
-319,286
-17% -$16M 0.02% 506
2025
Q2 		$101M Sell
1,909,413
-1,219,545
-39% -$62M 0.02% 534
2025
Q1 		$135M Buy
3,128,958
+1,707,287
+120% +$86.5M 0.03% 457
2024
Q4 		$79.9M Buy
1,421,671
+81,774
+6% +$5.09M 0.02% 562
2024
Q3 		$91.3M Sell
1,339,897
-423,648
-24% -$23.9M 0.02% 541
2024
Q2 		$74.5M Buy
1,763,545
+449,075
+34% +$24.7M 0.02% 525
2024
Q1 		$90.8M Buy
1,314,470
+533,631
+68% +$33.8M 0.03% 471
2023
Q4 		$57.8M Buy
780,839
+59,236
+8% +$3.88M 0.02% 553
2023
Q3 		$49.2M Buy
721,603
+116,677
+19% +$9.9M 0.02% 565
2023
Q2 		$41M Hold
604,926
– – 0.02% 603
2023
Q1 		$41M Buy
604,926
+23,367
+4% +$1.5M 0.02% 603
2022
Q4 		$28.8M Sell
581,559
-1,934
-0.3% -$79K 0.02% 672
2022
Q3 		$19M Sell
583,493
-32,190
-5% -$1.33M 0.01% 774
2022
Q2 		$24.3M Sell
615,683
-29,569
-5% -$1.58M 0.01% 691
2022
Q1 		$45.1M Buy
645,252
+19,644
+3% +$1.44M 0.02% 637
2021
Q4 		$48.7M Buy
625,608
+13,192
+2% +$1.16M 0.02% 666
2021
Q3 		$58.5M Buy
612,416
+12,266
+2% +$1.3M 0.02% 583
2021
Q2 		$74.6M Buy
600,150
+50,097
+9% +$5.98M 0.03% 520
2021
Q1 		$72.5M Buy
550,053
+45,694
+9% +$6.25M 0.03% 515
2020
Q4 		$66.8M Buy
504,359
+42,088
+9% +$5.09M 0.03% 508
2020
Q3 		$47.1M Sell
462,271
-7,049
-2% -$609K 0.03% 551
2020
Q2 		$40.8M Sell
469,320
-108,099
-19% -$8.64M 0.02% 556
2020
Q1 		$33.5M Sell
577,419
-26,177
-4% -$2.13M 0.02% 562
2019
Q4 		$55.8M Buy
603,596
+69,268
+13% +$6.09M 0.03% 499
2019
Q3 		$48.3M Buy
534,328
+39,149
+8% +$4.46M 0.03% 518
2019
Q2 		$58.5M Buy
495,179
+50,987
+11% +$5.14M 0.04% 466
2019
Q1 		$38.5M Buy
444,192
+12,093
+3% +$1.03M 0.03% 565
2018
Q4 		$27.3M Sell
432,099
-227,245
-34% -$15.6M 0.02% 629
2018
Q3 		$52M Sell
659,344
-80,249
-11% -$5.23M 0.04% 479
2018
Q2 		$44.2M Sell
739,593
-89,650
-11% -$4.82M 0.03% 548
2018
Q1 		$33.4M Sell
829,243
-44,323
-5% -$2.16M 0.03% 627
2017
Q4 		$45.9M Sell
873,566
-199,003
-19% -$10.6M 0.04% 481
2017
Q3 		$50.5M Sell
1,072,569
-494,727
-32% -$19.9M 0.05% 422
2017
Q2 		$55.4M Sell
1,567,296
-271,992
-15% -$8.4M 0.05% 384
2017
Q1 		$43.4M Sell
1,839,288
-36,117
-2% -$716K 0.04% 448
2016
Q4 		$25.1M Sell
1,875,405
-66,090
-3% -$1.07M 0.03% 596
2016
Q3 		$36.1M Sell
1,941,495
-17,458
-0.9% -$308K 0.04% 474
2016
Q2 		$24M Buy
1,958,953
+772,434
+65% +$5.82M 0.03% 605
2016
Q1 		$8M Buy
1,186,519
+32,579
+3% +$208K 0.01% 897
2015
Q4 		$10.7M Sell
1,153,940
-66,311
-5% -$617K 0.01% 844
2015
Q3 		$22M Buy
1,220,251
+41,846
+4% +$961K 0.02% 647
2015
Q2 		$35M Sell
1,178,405
-16,592
-1% -$417K 0.03% 530
2015
Q1 		$26.3M Buy
1,194,997
+291,100
+32% +$7.38M 0.03% 624
2014
Q4 		$24.8M Buy
903,897
+417,500
+86% +$10.2M 0.02% 634
2014
Q3 		$9.43M Sell
486,397
-38,683
-7% -$709K 0.01% 853
2014
Q2 		$8.94M Buy
525,080
+172,183
+49% +$2.37M 0.01% 885
2014
Q1 		$5M Sell
352,897
-52,400
-13% -$708K 0.01% 1040
2013
Q4 		$4.74M Sell
405,297
-27,100
-6% -$311K 0.01% 1019
2013
Q3 		$5.11M Buy
432,397
+14,000
+3% +$180K 0.01% 979
2013
Q2 		$5.82M Buy
+418,397
New +$4.55M 0.01% 920

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

UBS AM's EXAS Position: Q1 2026 in Review

UBS AM sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 615,940 shares — an estimated $62.6M sold.

UBS AM first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $135M in Q1 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • UBS AM reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • UBS AM sold 615,940 Exact Sciences shares in Q1 2026, an estimated $62.6M.
  • UBS AM first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • UBS AM's Exact Sciences position peaked at $135M in Q1 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.